SMS Pharmaceuticals Ltd — Call Transcript 2022

Jun 6, 2022

==> picture [241 x 158] intentionally omitted <==

Date: 06[th] June, 2022

To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

Security Code: 532815

The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051.

Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Audio recording of Analysts/Investors Conference Call pertaining to the Financial Results for the fourth quarter and year ended 31[st] March, 2022.

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, and further to our letter dated 02[nd] June 2022 regarding intimation of Investors/ Analyst conference call held on today i.e., 06[th] June, 2022, on the Audited Financial Results of the Company for the fourth quarter and financial year ended 31[st] March, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company’s website. This can be accessed via the following link.

https://smspharma.com/wp-content/uploads/2022/06/Q4FY22-Concall-AudioTranscript.mp3

You are requested to take the same on record.

Thanking you

Yours Faithfully

==> picture [199 x 96] intentionally omitted <==